Vertex Pharmaceuticals | VRTX - Ação

Preço das Ações
430.14
Mudança Diária
4.13 0.97%
Mensal
-2.94%
Anual
-14.57%
Q2 Previsão
421.08




Ação Alterar Data
AbbVie USD 4.95B 13M 2025-12
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Gilead Sciences USD 1.77B 11M 2025-12
Incyte USD 115.62M 14.56M 2026-03
Insmed USD 132.07M 11.1M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
J&J USD 14.58B 392M 2026-03
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.27B 152M 2025-12
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12